PIXE studies of osteoporosis preventive treatments

Abstract Particle induced X-ray emission (PIXE) and nuclear microprobe (NMP) have been used in an exploratory work to study elemental alterations in tissues of experimental animals submitted to osteoporosis preventive treatments. Osteopathologies have been associated with several factors, such as hormonal disturbances, metabolic aberrations, low dietary Ca and vitamin D intake, excess of iron, among other possible factors. Hormonal treatments seem to be beneficial to the incorporation of Ca in bone but breast and endometrial cancers constitute significant side effects that cannot be ignored. Wistar female rats were used to test the effect of estrogen therapy in osteoporosis progression. The variations of elemental concentrations in uterus and the Ca content of femoral bones of ovariectomised rats under estrogen therapy were investigated. PIXE, Rutherford backscattering spectrometry and secondary electron microscopy techniques were applied for the characterisation of biological materials, with respect to morphology and trace element distribution determination. The increase of Ca and Fe concentrations in uterus and the variations for Ca distribution patterns in bone of rats submitted to estrogen therapy were the major features observed.

[1]  E. D. Harris,et al.  Regulation of antioxidant enzymes 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  G. Grime,et al.  RECENT DEVELOPMENTS IN DATA-ACQUISITION AND PROCESSING ON THE OXFORD SCANNING PROTON MICROPROBE , 1995 .

[3]  M. Stoeppler.  Sampling and Sample Preparation , 1997 .

[4]  Y. Hiraku,et al.  Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation , 2001, International journal of cancer.

[5]  Y. Lee,et al.  Inhibitors of Na+/Ca2+ exchanger prevent oxidant-induced intracellular Ca2+ increase and apoptosis in a human hepatoma cell line , 2000, Free radical research.

[6]  M. Kleerekoper,et al.  Comparative Safety of Bone Remodeling Agents with a Focus on Osteoporosis Therapies , 2001, Journal of clinical pharmacology.

[7]  Eric Ziegl,et al.  Statistical Methods for the Analysis of Biomedical Data , 1989 .

[8]  K. Pritchard.  The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Penckofer,et al.  Improved iron status parameters may be a benefit of hormone replacement therapy. , 2000, Journal of women's health & gender-based medicine.

[10]  V. Jordan,et al.  Novel agents to modulate oestrogen action. , 2000, British medical bulletin.

[11]  W. Maenhaut,et al.  An intercomparison of spectral data processing techniques in PIXE , 1986 .

[12]  L. Berstein,et al.  Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. , 1996, Mutation research.

[13]  S. Toyokuni,et al.  Iron-induced carcinogenesis: the role of redox regulation. , 1996, Free radical biology & medicine.

[14]  L. Baeksgaard,et al.  Response of Cortical Bone to Antiresorptive Treatment , 2001, Calcified Tissue International.

[15]  M. Reis,et al.  DATTPIXE, a computer package for TTPIXE data analysis , 1992 .

[16]  Marija J. Norusis,et al.  Spss for Windows: Professional Statistics User's Guide, Release 5.0. , 1994 .

[17]  B. Halliwell,et al.  The measurement and mechanism of lipid peroxidation in biological systems. , 1990, Trends in biochemical sciences.